the salivary concentration of 17-hydroxyprogesterone ( 17-ohp ) was determined in 11 patients ( aged 6 months to 13 years ) with congenital adrenogenital syndrome ( ags ) due to c21-hydroxylase deficiency and six healthy controls , in order to assess its value in monitoring treatment of ags .
C0302280
congenital adrenogenital syndrome
C0001627
ags